{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:26:31Z","timestamp":1792016791398,"version":"4.4.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10802-x","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T09:59:56Z","timestamp":1751968796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rett syndrome: advances in Understanding MeCP2 function, potential gene therapies, and public health implications"],"prefix":"10.1007","volume":"52","author":[{"given":"Nadia E.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeela","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Abalkhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasleem","family":"Kausar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad I.","family":"Aqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"10802_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/acschemneuro.7b00346","volume":"9","author":"WA Gold","year":"2018","unstructured":"Gold WA, Krishnarajy R, Ellaway C, Christodoulou J (2018) Rett syndrome: a genetic update and clinical review focusing on comorbidities. ACS Chem Neurosci 9:167\u2013176","journal-title":"ACS Chem Neurosci"},{"key":"10802_CR2","doi-asserted-by":"crossref","unstructured":"Percy AK (2016) Rett syndrome: seeing the way forward. Health care for people with intellectual and developmental. Disabil Lifesp 765\u2013777","DOI":"10.1007\/978-3-319-18096-0_65"},{"key":"10802_CR3","doi-asserted-by":"crossref","unstructured":"Schmitt I, Evert BO, Sharma A, Khazneh H, Murgatroyd C, W\u00fcllner U (2024) The alpha-synuclein gene (SNCA) is a genomic target of Methyl-CpG binding protein 2 (MeCP2)\u2014Implications for parkinson\u2019s disease and Rett syndrome. Mol Neurobiol 1\u201315","DOI":"10.1007\/s12035-024-03974-3"},{"key":"10802_CR4","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.3390\/ijms20163925","volume":"20","author":"S Vidal","year":"2019","unstructured":"Vidal S, Xiol C, Pascual-Alonso A, O\u2019callaghan M, Pineda M, Armstrong J (2019) Genetic landscape of Rett syndrome spectrum: improvements and challenges. Int J Mol Sci 20:3925","journal-title":"Int J Mol Sci"},{"key":"10802_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2018.08.022","volume":"88","author":"GS Townend","year":"2018","unstructured":"Townend GS, van de Berg R, de Breet LHM, Hiemstra M, Wagter L, Smeets E, Widdershoven J, Kingma H, Curfs LMG (2018) Oculomotor function in individuals with Rett syndrome. Pediatr Neurol 88:48\u201358","journal-title":"Pediatr Neurol"},{"key":"10802_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/09638280150504171","volume":"23","author":"JCE Christodoulou","year":"2001","unstructured":"Christodoulou JCE (2001) Rett syndrome: clinical characteristics and recent genetic advances. Disabil Rehabil 23:98\u2013106","journal-title":"Disabil Rehabil"},{"key":"10802_CR7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/13696998.2023.2286778","volume":"26","author":"DM May","year":"2023","unstructured":"May DM, Neul JL, Satija A, Cheng WY, Lema N, Boca A, Lefebvre P, Pi\u00f1a-Garza JE (2023) Real-world clinical management of individuals with Rett syndrome: a physician survey. J Med Econ 26:1570\u20131580","journal-title":"J Med Econ"},{"key":"10802_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.17219\/dmp\/99203","volume":"55","author":"E Bianco","year":"2018","unstructured":"Bianco E, Rota D (2018) Oral findings in Rett syndrome: an update and review of the literature [Zmiany w jamie ustnej w zespole Retta\u2013Przegl\u0105d wsp\u00f3\u0142czesnego pi\u015bmiennictwa]. Dent Med Probl 55:441\u2013445","journal-title":"Dent Med Probl"},{"key":"10802_CR9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0387-7604(12)80045-3","volume":"13","author":"A Hussain","year":"1991","unstructured":"Hussain A, Khan MA, Qazi SA, Rehman GN (1991) The Rett syndrome: the first case report from Pakistan. Brain Dev 13:442\u2013444","journal-title":"Brain Dev"},{"key":"10802_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.37185\/LnS.1.1.77","volume":"1","author":"R Dad","year":"2020","unstructured":"Dad R, Sawal HA, Ahmad A, Ullah MI, Hassan MJ (2020) Rett syndrome without MECP2 mutation in a Pakistani Girl. Life Sci 1:3","journal-title":"Life Sci"},{"key":"10802_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422\u2013437","journal-title":"Neuron"},{"key":"10802_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.52711\/2321-5836.2023.00029","volume":"15","author":"SSS Narava","year":"2023","unstructured":"Narava SSS, Kucherlapati S, Mugada VK, Yarguntla SR (2023) A review on Rett syndrome: A debilitating neurodevelopmental disorder. Res J Pharmacol Pharmacodynamics 15:159\u2013164","journal-title":"Res J Pharmacol Pharmacodynamics"},{"key":"10802_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejpn.2020.06.020","volume":"28","author":"S Brunetti","year":"2020","unstructured":"Brunetti S, Lumsden DE (2020) Rett syndrome as a movement and motor disorder\u2013A narrative review. Eur J Pediatr Neurol 28:29\u201337","journal-title":"Eur J Pediatr Neurol"},{"key":"10802_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-323-91532-8.00018-5","volume":"189","author":"J-M Ramirez","year":"2022","unstructured":"Ramirez J-M, Karlen-Amarante M, Huff A, Burgraff N (2022) Breathing disturbances in Rett syndrome. Handb Clin Neurol 189:139\u2013151","journal-title":"Handb Clin Neurol"},{"key":"10802_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-023-02994-x","volume":"19","author":"S Amin","year":"2024","unstructured":"Amin S, Ruban-Fell B, Newell I, Evans J, Vyas K, Nortvedt C, Chin RF (2024) Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex. Orphanet J Rare Dis 19:89","journal-title":"Orphanet J Rare Dis"},{"key":"10802_CR16","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1097\/BSD.0000000000001381","volume":"36","author":"S Menachem","year":"2023","unstructured":"Menachem S, Hershkovich O, Ackshota N, Friedlander A, Givon U, Ben-Zeev B, Caspi I (2023) Scoliosis in Rett syndrome: a National referral centre experience. Clin Spine Surg 36:E75\u2013E79","journal-title":"Clin Spine Surg"},{"key":"10802_CR17","doi-asserted-by":"crossref","first-page":"1048278","DOI":"10.3389\/fnins.2023.1048278","volume":"17","author":"R Cordani","year":"2023","unstructured":"Cordani R, Tobaldini E, Rodrigues GD, Giambersio D, Veneruso M, Chiarella L, Disma N, De Grandis E, Toschi-Dias E, Furlan L (2023) Cardiac autonomic control in Rett syndrome: insights from heart rate variability analysis. Front Neurosci 17:1048278","journal-title":"Front Neurosci"},{"key":"10802_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/dmcn.14657","volume":"63","author":"K Williams","year":"2021","unstructured":"Williams K, Jacoby P, Whitehouse A, Kim R, Epstein A, Murphy N, Reid S, Leonard H, Reddihough D, Downs J (2021) Functioning, participation, and quality of life in children with intellectual disability: an observational study. Dev Med Child Neurol 63:89\u201396","journal-title":"Dev Med Child Neurol"},{"key":"10802_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/brain\/awy323","volume":"142","author":"A Banerjee","year":"2019","unstructured":"Banerjee A, Miller MT, Li K, Sur M, Kaufmann WE (2019) Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder. Brain 142:239\u2013248","journal-title":"Brain"},{"key":"10802_CR20","doi-asserted-by":"crossref","first-page":"1477227","DOI":"10.3389\/fendo.2024.1477227","volume":"15","author":"G Pepe","year":"2024","unstructured":"Pepe G, Coco R, Corica D, Luppino G, Morabito LA, Lugar\u00e0 C, Abbate T, Zirilli G, Aversa T, Stagi S (2024) Endocrine disorders in Rett syndrome: a systematic review of the literature. Front Endocrinol (Lausanne) 15:1477227","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10802_CR21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.22154","volume":"68","author":"AK Percy","year":"2010","unstructured":"Percy AK, Neul JL, Glaze DG, Motil KJ, Skinner SA, Khwaja O, Lee H, Lane JB, Barrish JO, Annese F (2010) Rett syndrome diagnostic criteria: lessons from the natural history study. Ann Neurol 68:951\u2013955","journal-title":"Ann Neurol"},{"key":"10802_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.braindev.2018.08.008","volume":"41","author":"CB Buchanan","year":"2019","unstructured":"Buchanan CB, Stallworth JL, Scott AE, Glaze DG, Lane JB, Skinner SA, Tierney AE, Percy AK, Neul JL, Kaufmann WE (2019) Behavioral profiles in Rett syndrome: data from the natural history study. Brain Dev 41:123\u2013134","journal-title":"Brain Dev"},{"key":"10802_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2004.027730","volume":"42","author":"LS Weaving","year":"2005","unstructured":"Weaving LS, Ellaway CJ, Gecz J, Christodoulou J (2005) Rett syndrome: clinical review and genetic update. J Med Genet 42:1\u20137","journal-title":"J Med Genet"},{"key":"10802_CR24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.0b013e3181d6b852","volume":"74","author":"DG Glaze","year":"2010","unstructured":"Glaze DG, Percy AK, Skinner S, Motil KJ, Neul JL, Barrish JO, Lane JB, Geerts SP, Annese F, Graham J (2010) Epilepsy and the natural history of Rett syndrome. Neurology 74:909\u2013912","journal-title":"Neurology"},{"key":"10802_CR25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"JL Neul","year":"2010","unstructured":"Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, Leonard H, Bailey MES, Schanen NC, Zappella M (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68:944\u2013950","journal-title":"Ann Neurol"},{"key":"10802_CR26","doi-asserted-by":"crossref","unstructured":"Krajnc N (2015) Management of epilepsy in patients with Rett syndrome: perspectives and considerations. Ther Clin Risk Manag:925\u2013932","DOI":"10.2147\/TCRM.S55896"},{"key":"10802_CR27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/humu.23409","volume":"39","author":"TI Sheikh","year":"2018","unstructured":"Sheikh TI, Harripaul R, Ayub M, Vincent JB (2018) MeCP2 AT-Hook1 mutations in patients with intellectual disability and\/or schizophrenia disrupt DNA binding and chromatin compaction in vitro. Hum Mutat 39:717\u2013728","journal-title":"Hum Mutat"},{"key":"10802_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/YPG.0000000000000165","volume":"27","author":"A Curie","year":"2017","unstructured":"Curie A, Lesca G, Bussy G, Manificat S, Arnaud V, Gonzalez S, Revol O, Calender A, G\u00e9rard D (2017) Des Portes V. Asperger syndrome and early-onset schizophrenia associated with a novel MECP2 deleterious missense variant. Psychiatr Genet 27:105\u2013109","journal-title":"Psychiatr Genet"},{"key":"10802_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0387-7604(87)80062-1","volume":"9","author":"B Hagberg","year":"1987","unstructured":"Hagberg B, Witt-Engerstr\u00f6m I (1987) Rett syndrome: epidemiology and nosology\u2014progress in knowledge 1986\u2014a conference communication. Brain Dev 9:451\u2013457","journal-title":"Brain Dev"},{"key":"10802_CR30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ajmg.10005","volume":"104","author":"M Zappella","year":"2001","unstructured":"Zappella M, Meloni I, Longo I, Hayek G, Renieri A (2001) Preserved speech variants of the Rett syndrome: molecular and clinical analysis. Am J Med Genet 104:14\u201322","journal-title":"Am J Med Genet"},{"key":"10802_CR31","doi-asserted-by":"crossref","first-page":"e01250","DOI":"10.1002\/brb3.1250","volume":"9","author":"FF Operto","year":"2019","unstructured":"Operto FF, Mazza R, Pastorino GMG, Verrotti A, Coppola G (2019) Epilepsy and genetic in Rett syndrome: A review. Brain Behav 9:e01250","journal-title":"Brain Behav"},{"key":"10802_CR32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.braindev.2008.04.007","volume":"31","author":"A Renieri","year":"2009","unstructured":"Renieri A, Mari F, Mencarelli MA, Scala E, Ariani F, Longo I, Meloni I, Cevenini G, Pini G, Hayek G (2009) Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev 31:208\u2013216","journal-title":"Brain Dev"},{"key":"10802_CR33","doi-asserted-by":"crossref","first-page":"1172805","DOI":"10.3389\/fnins.2023.1172805","volume":"17","author":"M Palmieri","year":"2023","unstructured":"Palmieri M, Pozzer D, Landsberger N (2023) Advanced genetic therapies for the treatment of Rett syndrome: state of the Art and future perspectives. Front Neurosci 17:1172805","journal-title":"Front Neurosci"},{"key":"10802_CR34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajhg.2008.05.015","volume":"83","author":"F Ariani","year":"2008","unstructured":"Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, Pollazzon M, Buoni S, Spiga O, Ricciardi S (2008) FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 83:89\u201393","journal-title":"Am J Hum Genet"},{"key":"10802_CR35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/ijms23020954","volume":"23","author":"I Akol","year":"2022","unstructured":"Akol I, Gather F, Vogel T (2022) Paving therapeutic avenues for FOXG1 syndrome: untangling genotypes and phenotypes from a molecular perspective. Int J Mol Sci 23:954","journal-title":"Int J Mol Sci"},{"key":"10802_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0032-1308856","volume":"43","author":"G Pini","year":"2012","unstructured":"Pini G, Bigoni S, Engerstr\u00f6m IW, Calabrese O, Felloni B, Scusa MF, Di Marco P, Borelli P, Bonuccelli U, Julu POO (2012) Variant of Rett syndrome and CDKL5 gene: clinical and autonomic description of 10 cases. Neuropediatrics 43:37\u201343","journal-title":"Neuropediatrics"},{"key":"10802_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jmg.2009.067884","volume":"47","author":"MA Mencarelli","year":"2010","unstructured":"Mencarelli MA, Spanhol-Rosseto A, Artuso R, Rondinella D, De Filippis R, Bahi-Buisson N, Nectoux J, Rubinsztajn R, Bienvenu T, Moncla A (2010) Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 47:49\u201353","journal-title":"J Med Genet"},{"key":"10802_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.braindev.2009.02.004","volume":"32","author":"R Artuso","year":"2010","unstructured":"Artuso R, Mencarelli MA, Polli R, Sartori S, Ariani F, Pollazzon M, Marozza A, Cilio MR, Specchio N, Vigevano F (2010) Early-onset seizure variant of Rett syndrome: definition of the clinical diagnostic criteria. Brain Dev 32:17\u201324","journal-title":"Brain Dev"},{"key":"10802_CR39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(20)30217-9","volume":"19","author":"AJ Sandweiss","year":"2020","unstructured":"Sandweiss AJ, Brandt VL, Zoghbi HY (2020) Advances in Understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. Lancet Neurol 19:689\u2013698","journal-title":"Lancet Neurol"},{"key":"10802_CR40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12883-023-03181-y","volume":"23","author":"D May","year":"2023","unstructured":"May D, Kponee-Shovein K, Mahendran M, Downes N, Sheng K, Lefebvre P, Cheng WY (2023) Epidemiology and patient journey of Rett syndrome in the united states: a real-world evidence study. BMC Neurol 23:141","journal-title":"BMC Neurol"},{"key":"10802_CR41","unstructured":"Handbook of Clinical Neurology Series (2018) The cerebellum: disorders and treatment, vol 155. 1st ed. Elsevier"},{"key":"10802_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","volume":"12","author":"U Petriti","year":"2023","unstructured":"Petriti U, Dudman DC, Scosyrev E, Lopez-Leon S (2023) Global prevalence of Rett syndrome: systematic review and meta-analysis. Syst Rev 12:5","journal-title":"Syst Rev"},{"key":"10802_CR43","unstructured":"Kerr AM (1992) Mental retardation and medical care, April 21\u201324 1991"},{"key":"10802_CR44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0387-7604(97)00572-X","volume":"19","author":"OH Skjeldal","year":"1997","unstructured":"Skjeldal OH, von Tetzchner S, Aspelund F, Herder GA, Lofter\u00f8d B (1997) Rett syndrome: geographic variation in prevalence in Norway. Brain Dev 19:258\u2013261","journal-title":"Brain Dev"},{"key":"10802_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0387-7604(95)00002-S","volume":"17","author":"K Terai","year":"1995","unstructured":"Terai K, Munesue T, Hiratani M, Zheng-Yan J, Jibiki I, Yamaguchi N (1995) The prevalence of Rett syndrome in Fukui Prefecture. Brain Dev 17:153\u2013154","journal-title":"Brain Dev"},{"key":"10802_CR46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pediatrneurol.2005.10.013","volume":"34","author":"T Bienvenu","year":"2006","unstructured":"Bienvenu T, Philippe C, De Roux N, Raynaud M, Bonnefond JP, Pasquier L, Lesca G, Mancini J, Jonveaux P, Moncla A (2006) The incidence of Rett syndrome in France. Pediatr Neurol 34:372\u2013375","journal-title":"Pediatr Neurol"},{"key":"10802_CR47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","volume":"148","author":"CL Laurvick","year":"2006","unstructured":"Laurvick CL, De Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in australia: a review of the epidemiology. J Pediatr 148:347\u2013352","journal-title":"J Pediatr"},{"key":"10802_CR48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0387-7604(12)80201-4","volume":"12","author":"SB Hanks","year":"1990","unstructured":"Hanks SB (1990) Motor disabilities in the Rett syndrome and physical therapy strategies. Brain Dev 12:157\u2013161","journal-title":"Brain Dev"},{"key":"10802_CR49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","volume":"14","author":"B Hagberg","year":"1983","unstructured":"Hagberg B, Aicardi J, Dias K, Ramos O (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: rett\u2019s syndrome: report of 35 cases. Annals Neurology: Official J Am Neurol Association Child Neurol Soc 14:471\u2013479","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"key":"10802_CR50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1212\/01.wnl.0000304752.50773.ec","volume":"70","author":"A Bebbington","year":"2008","unstructured":"Bebbington A, Anderson A, Ravine D, Fyfe S, Pineda M, De Klerk N, Ben-Zeev B, Yatawara N, Percy A, Kaufmann WE (2008) Investigating genotype\u2013phenotype relationships in Rett syndrome using an international data set. Neurology 70:868\u2013875","journal-title":"Neurology"},{"key":"10802_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.32707","volume":"180","author":"JL Neul","year":"2019","unstructured":"Neul JL, Benke TA, Marsh ED, Skinner SA, Merritt J, Lieberman DN, Standridge S, Feyma T, Heydemann P, Peters S (2019) The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. Am J Med Genet Part B: Neuropsychiatric Genet 180:55\u201367","journal-title":"Am J Med Genet Part B: Neuropsychiatric Genet"},{"key":"10802_CR52","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neubiorev.2019.01.028","volume":"98","author":"C Einspieler","year":"2019","unstructured":"Einspieler C, Marschik PB (2019) Regression in Rett syndrome: developmental pathways to its onset. Neurosci Biobehav Rev 98:320\u2013332","journal-title":"Neurosci Biobehav Rev"},{"key":"10802_CR53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.ejhg.5201580","volume":"14","author":"SL Williamson","year":"2006","unstructured":"Williamson SL, Christodoulou J (2006) Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 14:896\u2013903","journal-title":"Eur J Hum Genet"},{"key":"10802_CR54","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/sj.ejhg.5201911","volume":"15","author":"SA Hardwick","year":"2007","unstructured":"Hardwick SA, Reuter K, Williamson SL, Vasudevan V, Donald J, Slater K, Bennetts B, Bebbington A, Leonard H, Williams SR (2007) Delineation of large deletions of the MECP2 gene in Rett syndrome patients, including a Familial case with a male proband. Eur J Hum Genet 15:1218\u20131229","journal-title":"Eur J Hum Genet"},{"key":"10802_CR55","doi-asserted-by":"crossref","first-page":"10375","DOI":"10.3390\/ijms221910375","volume":"22","author":"C Xiol","year":"2021","unstructured":"Xiol C, Heredia M, Pascual-Alonso A, Oyarzabal A, Armstrong J (2021) Technological improvements in the genetic diagnosis of Rett syndrome spectrum disorders. Int J Mol Sci 22:10375","journal-title":"Int J Mol Sci"},{"key":"10802_CR56","unstructured":"Benke TA, Demarest S, Angione K, Downs J, Leonard H, Saldaris J, Marsh ED, Olson H, Haviland I (2024) CDKL5 Deficiency Disorder. GeneReviews\u00ae[Internet]"},{"key":"10802_CR57","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2014.14604","volume":"312","author":"H Lee","year":"2014","unstructured":"Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, Das K, Toy T, Harry B, Yourshaw M (2014) Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312:1880\u20131887","journal-title":"JAMA"},{"key":"10802_CR58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cge.13102","volume":"93","author":"E Ch\u00e9rot","year":"2018","unstructured":"Ch\u00e9rot E, Keren B, Dubourg C, Carr\u00e9 W, Fradin M, Lavillaureix A, Afenjar A, Burglen L, Whalen S, Charles P (2018) Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of 2 clinical units and 216 patients. Clin Genet 93:567\u2013576","journal-title":"Clin Genet"},{"key":"10802_CR59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/9.7.1119","volume":"9","author":"JP Cheadle","year":"2000","unstructured":"Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, Krawczak M, Cooper DN, Lynch S, Thomas N (2000) Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9:1119\u20131129","journal-title":"Hum Mol Genet"},{"key":"10802_CR60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20046","volume":"23","author":"S Tomatsu","year":"2004","unstructured":"Tomatsu S, Orii KO, Bi Y, Gutierrez MA, Nishioka T, Yamaguchi S, Kondo N, Orii T, Noguchi A, Sly WS (2004) General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2\u2010sulfatase gene locus. Hum Mutat 23:590\u2013598","journal-title":"Hum Mutat"},{"key":"10802_CR61","doi-asserted-by":"crossref","first-page":"838206","DOI":"10.3389\/fneur.2022.838206","volume":"13","author":"Y Kong","year":"2022","unstructured":"Kong Y, Li Q, Yuan Z, Jiang X, Zhang G, Cheng N, Dang N (2022) Multimodal neuroimaging in Rett syndrome with MECP2 mutation. Front Neurol 13:838206","journal-title":"Front Neurol"},{"key":"10802_CR62","unstructured":"Hoffman M (2016) Kathryn Whitbourne. What Is Rett Syndrome? WebMD"},{"key":"10802_CR63","doi-asserted-by":"crossref","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","volume":"12","author":"KV Good","year":"2021","unstructured":"Good KV, Vincent JB, Ausi\u00f3 J (2021) MeCP2: the genetic driver of Rett syndrome epigenetics. Front Genet 12:620859","journal-title":"Front Genet"},{"key":"10802_CR64","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/302690","volume":"65","author":"M Wan","year":"1999","unstructured":"Wan M, Lee SSJ, Zhang X, Houwink-Manville I, Song H-R, Amir RE, Budden S, Naidu S, Pereira JLP, Lo IFM (1999) Rett syndrome and beyond: recurrent spontaneous and Familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65:1520\u20131529","journal-title":"Am J Hum Genet"},{"key":"10802_CR65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/382228","volume":"74","author":"JI Young","year":"2004","unstructured":"Young JI, Zoghbi HY (2004) X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am J Hum Genet 74:511\u2013520","journal-title":"Am J Hum Genet"},{"key":"10802_CR66","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.3390\/ijms20184577","volume":"20","author":"K Gulmez Karaca","year":"2019","unstructured":"Gulmez Karaca K, Brito DVC, Oliveira AMM (2019) MeCP2: a critical regulator of chromatin in neurodevelopment and adult brain function. Int J Mol Sci 20:4577","journal-title":"Int J Mol Sci"},{"key":"10802_CR67","doi-asserted-by":"crossref","first-page":"e1000179","DOI":"10.1371\/journal.pgen.1000179","volume":"4","author":"HN Cukier","year":"2008","unstructured":"Cukier HN, Perez AM, Collins AL, Zhou Z, Zoghbi HY, Botas J (2008) Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet 4:e1000179","journal-title":"PLoS Genet"},{"key":"10802_CR68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41422-020-0288-7","volume":"30","author":"L Wang","year":"2020","unstructured":"Wang L, Hu M, Zuo M-Q, Zhao J, Wu D, Huang L, Wen Y, Li Y, Chen P, Bao X (2020) Rett syndrome-causing mutations compromise MeCP2-mediated liquid\u2013liquid phase separation of chromatin. Cell Res 30:393\u2013407","journal-title":"Cell Res"},{"key":"10802_CR69","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/19491034.2016.1211217","volume":"7","author":"M Tyagi","year":"2016","unstructured":"Tyagi M, Imam N, Verma K, Patel AK (2016) Chromatin remodelers: we are the drivers!! Nucleus 7:388\u2013404","journal-title":"Nucleus"},{"key":"10802_CR70","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.ejhg.5201451","volume":"13","author":"JC Evans","year":"2005","unstructured":"Evans JC, Archer HL, Colley JP, Ravn K, Nielsen JB, Kerr A, Williams E, Christodoulou J, G\u00e9cz J, Jardine PE (2005) Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 13:1113\u20131120","journal-title":"Eur J Hum Genet"},{"key":"10802_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0545-5","volume":"11","author":"F Ehrhart","year":"2016","unstructured":"Ehrhart F, Coort SLM, Cirillo E, Smeets E, Evelo CT, Curfs LMG (2016) Rett syndrome\u2013biological pathways leading from MECP2 to disorder phenotypes. Orphanet J Rare Dis 11:1\u201313","journal-title":"Orphanet J Rare Dis"},{"key":"10802_CR72","doi-asserted-by":"crossref","first-page":"105043","DOI":"10.1016\/j.nbd.2020.105043","volume":"145","author":"C Miranda-Louren\u00e7o","year":"2020","unstructured":"Miranda-Louren\u00e7o C, Duarte ST, Palminha C, Gaspar C, Rodrigues TM, Magalh\u00e3es-Cardoso T, Rei N, Colino-Oliveira M, Gomes R, Ferreira S (2020) Impairment of adenosinergic system in Rett syndrome: novel therapeutic target to boost BDNF signalling. Neurobiol Dis 145:105043","journal-title":"Neurobiol Dis"},{"key":"10802_CR73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnsys.2018.00069","volume":"12","author":"AX Xie","year":"2019","unstructured":"Xie AX, Pan X-Q, Meacham RB, Malykhina AP (2019) The expression of transcription factors Mecp2 and CREB is modulated in inflammatory pelvic pain. Front Syst Neurosci 12:69","journal-title":"Front Syst Neurosci"},{"key":"10802_CR74","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fgene.2018.00635","volume":"9","author":"CO Olson","year":"2018","unstructured":"Olson CO, Pejhan S, Kroft D, Sheikholeslami K, Fuss D, Buist M, Ali Sher A, Del Bigio MR, Sztainberg Y, Siu VM (2018) MECP2 mutation interrupts nucleolin\u2013mTOR\u2013P70S6K signaling in Rett syndrome patients. Front Genet 9:635","journal-title":"Front Genet"},{"key":"10802_CR75","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2217\/epi.15.39","volume":"7","author":"Q Du","year":"2015","unstructured":"Du Q, Luu P-L, Stirzaker C, Clark SJ (2015) Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7:1051\u20131073","journal-title":"Epigenomics"},{"key":"10802_CR76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10048-008-0161-1","volume":"10","author":"Y Fichou","year":"2009","unstructured":"Fichou Y, Nectoux J, Bahi-Buisson N, Rosas-Vargas H, Girard B, Chelly J, Bienvenu T (2009) The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform. Neurogenetics 10:127\u2013133","journal-title":"Neurogenetics"},{"key":"10802_CR77","doi-asserted-by":"crossref","first-page":"e90645","DOI":"10.1371\/journal.pone.0090645","volume":"9","author":"CO Olson","year":"2014","unstructured":"Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VRB, Rastegar M (2014) Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS ONE 9:e90645","journal-title":"PLoS ONE"},{"key":"10802_CR78","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1073\/pnas.1505909112","volume":"112","author":"L Chen","year":"2015","unstructured":"Chen L, Chen K, Lavery LA, Baker SA, Shaw CA, Li W, Zoghbi HY (2015) MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc Natl Acad Sci 112:5509\u20135514","journal-title":"Proc Natl Acad Sci"},{"key":"10802_CR79","doi-asserted-by":"crossref","unstructured":"Sripathy S, Leko V, Adrianse RL, Loe T, Foss EJ, Dalrymple E, Lao U, Gatbonton-Schwager T, Carter KT, Payer B (2017) Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP\/TGF-\u03b2 superfamily as a regulator of XIST expression. Proceedings of the National Academy of Sciences.;114:1619\u201324","DOI":"10.1073\/pnas.1621356114"},{"key":"10802_CR80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2008.10.036","volume":"65","author":"LM Monteggia","year":"2009","unstructured":"Monteggia LM, Kavalali ET (2009) Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol Psychiatry 65:204\u2013210","journal-title":"Biol Psychiatry"},{"key":"10802_CR81","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst MJ, Bird A (2015) Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 16:261\u2013275","journal-title":"Nat Rev Genet"},{"key":"10802_CR82","unstructured":"Laura Hergott (2022) Defects in autophagy are implicated in a Mecp2-mutant mouse model of Rett syndrome. Master\u2019s thesis. University of Toronto"},{"key":"10802_CR83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2017.00058","volume":"11","author":"N Shulyakova","year":"2017","unstructured":"Shulyakova N, Andreazza AC, Mills LR, Eubanks JH (2017) Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies. Front Cell Neurosci 11:58","journal-title":"Front Cell Neurosci"},{"key":"10802_CR84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12859-015-0859-7","volume":"17","author":"M Vacca","year":"2016","unstructured":"Vacca M, Tripathi KP, Speranza L, Aiese Cigliano R, Scalabr\u00ec F, Marracino F, Madonna M, Sanseverino W, Perrone-Capano C, Guarracino MR (2016) Effects of Mecp2 loss of function in embryonic cortical neurons: a bioinformatics strategy to sort out non-neuronal cells variability from transcriptome profiling. BMC Bioinformatics 17:189\u2013201","journal-title":"BMC Bioinformatics"},{"key":"10802_CR85","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","volume":"26","author":"F Bedogni","year":"2016","unstructured":"Bedogni F, Cobolli Gigli C, Pozzi D, Rossi RL, Scaramuzza L, Rossetti G, Pagani M, Kilstrup-Nielsen C, Matteoli M, Landsberger N (2016) Defects during Mecp2 null embryonic cortex development precede the onset of overt neurological symptoms. Cereb Cortex 26:2517\u20132529","journal-title":"Cereb Cortex"},{"key":"10802_CR86","doi-asserted-by":"crossref","first-page":"e14199","DOI":"10.7554\/eLife.14199","volume":"5","author":"X Meng","year":"2016","unstructured":"Meng X, Wang W, Lu H, He L, Chen W, Chao ES, Fiorotto ML, Tang B, Herrera JA, Seymour ML (2016) Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders. Elife 5:e14199","journal-title":"Elife"},{"key":"10802_CR87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1097-2765(03)00276-4","volume":"12","author":"I Stancheva","year":"2003","unstructured":"Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR (2003) RETRACTED: A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol Cell 12:425\u2013435","journal-title":"Mol Cell"},{"key":"10802_CR88","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1091\/mbc.e11-09-0784","volume":"23","author":"T Squillaro","year":"2012","unstructured":"Squillaro T, Alessio N, Cipollaro M, Melone MAB, Hayek G, Renieri A, Giordano A, Galderisi U (2012) Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome. Mol Biol Cell 23:1435\u20131445","journal-title":"Mol Biol Cell"},{"key":"10802_CR89","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1523\/JNEUROSCI.1316-12.2012","volume":"32","author":"MVC Nguyen","year":"2012","unstructured":"Nguyen MVC, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N (2012) MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32:10021\u201310034","journal-title":"J Neurosci"},{"key":"10802_CR90","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","volume":"87","author":"SB Nelson","year":"2015","unstructured":"Nelson SB, Valakh V (2015) Excitatory\/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 87:684\u2013698","journal-title":"Neuron"},{"key":"10802_CR91","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/hmg\/ddu008","volume":"23","author":"EC Williams","year":"2014","unstructured":"Williams EC, Zhong X, Mohamed A, Li R, Liu Y, Dong Q, Ananiev GE, Mok JCC, Lin BR, Lu J (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23:2968\u20132980","journal-title":"Hum Mol Genet"},{"key":"10802_CR92","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.braindev.2008.12.021","volume":"32","author":"N Nakashima","year":"2010","unstructured":"Nakashima N, Yamagata T, Mori M, Kuwajima M, Suwa K, Momoi MY (2010) Expression analysis and mutation detection of DLX5 and DLX6 in autism. Brain Dev 32:98\u2013104","journal-title":"Brain Dev"},{"key":"10802_CR93","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddi097","volume":"14","author":"K Makedonski","year":"2005","unstructured":"Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS\/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14:1049\u20131058","journal-title":"Hum Mol Genet"},{"key":"10802_CR94","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/brain\/aws096","volume":"135","author":"L Robinson","year":"2012","unstructured":"Robinson L, Guy J, McKay L, Brockett E, Spike RC, Selfridge J, De Sousa D, Merusi C, Riedel G, Bird A (2012) Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135:2699\u20132710","journal-title":"Brain"},{"key":"10802_CR95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","volume":"5","author":"SE Sinnett","year":"2017","unstructured":"Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ (2017) Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery. Mol Ther Methods Clin Dev 5:106\u2013115","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10802_CR96","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1073\/pnas.1413620111","volume":"111","author":"S Bhatnagar","year":"2014","unstructured":"Bhatnagar S, Zhu X, Ou J, Lin L, Chamberlain L, Zhu LJ, Wajapeyee N, Green MR (2014) Genetic and Pharmacological reactivation of the mammalian inactive X chromosome. Proc Natl Acad Sci 111:12591\u201312598","journal-title":"Proc Natl Acad Sci"},{"key":"10802_CR97","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","volume":"35","author":"MD Shahbazian","year":"2002","unstructured":"Shahbazian MD, Young JI, Yuva-Paylor LA, Spencer CM, Antalffy BA, Noebels JL, Armstrong DL, Paylor R, Zoghbi HY (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35:243\u2013254","journal-title":"Neuron"},{"key":"10802_CR98","doi-asserted-by":"crossref","first-page":"170216","DOI":"10.1098\/rsob.170216","volume":"8","author":"SM Kyle","year":"2018","unstructured":"Kyle SM, Vashi N, Justice MJ (2018) Rett syndrome: a neurological disorder with metabolic components. Open Biol 8:170216","journal-title":"Open Biol"},{"key":"10802_CR99","first-page":"E2807","volume":"111","author":"C Li","year":"2014","unstructured":"Li C, Jiang S, Liu S-Q, Lykken E, Zhao L, Sevilla J, Zhu B, Li Q-J (2014) MeCP2 enforces Foxp3 expression to promote regulatory T cells\u2019 resilience to inflammation. Proc Natl Acad Sci 111:E2807\u2013E2816","journal-title":"Proc Natl Acad Sci"},{"key":"10802_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-016-0185-y","volume":"4","author":"F Strati","year":"2016","unstructured":"Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Pindo M, Renzi D (2016) Altered gut microbiota in Rett syndrome. Microbiome 4:1\u201315","journal-title":"Microbiome"},{"key":"10802_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-018-0785-z","volume":"18","author":"F Strati","year":"2018","unstructured":"Strati F, Calabr\u00f2 A, Donati C, De Felice C, Hayek J, Jousson O, Leoncini S, Renzi D, Rizzetto L, De Filippo C (2018) Intestinal Candida parapsilosis isolates from Rett syndrome subjects bear potential virulent traits and capacity to persist within the host. BMC Gastroenterol 18:1\u20139","journal-title":"BMC Gastroenterol"},{"key":"10802_CR102","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/ijms18020344","volume":"18","author":"E Borghi","year":"2017","unstructured":"Borghi E, Borgo F, Severgnini M, Savini MN, Casiraghi MC, Vignoli A (2017) Rett syndrome: a focus on gut microbiota. Int J Mol Sci 18:344","journal-title":"Int J Mol Sci"},{"key":"10802_CR103","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cellsig.2012.12.017","volume":"25","author":"C Miao","year":"2013","unstructured":"Miao C, Yang Y, He X, Li J (2013) New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2. Cell Signal 25:875\u2013882","journal-title":"Cell Signal"},{"key":"10802_CR104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2020.02.023","volume":"152","author":"A Pecorelli","year":"2020","unstructured":"Pecorelli A, Cervellati C, Cordone V, Hayek J, Valacchi G (2020) Compromised immune\/inflammatory responses in Rett syndrome. Free Radic Biol Med 152:100\u2013106","journal-title":"Free Radic Biol Med"},{"key":"10802_CR105","doi-asserted-by":"crossref","unstructured":"Khalid Iqbal M, Khan B, Hifsa, YuXuan G, Mujahid M, Kiyani MM, Khan H, Bashir S (2024) The impact of the Blood\u2013Brain barrier and its dysfunction in parkinson\u2019s disease. Contributions to Pathogenesis and Progression. ACS Omega","DOI":"10.1021\/acsomega.4c06546"},{"key":"10802_CR106","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","volume":"19","author":"SE Engelen","year":"2022","unstructured":"Engelen SE, Robinson AJB, Zurke Y-X, Monaco C (2022) Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol 19:522\u2013542","journal-title":"Nat Rev Cardiol"},{"key":"10802_CR107","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/adc.2005.090290","volume":"91","author":"M Acampa","year":"2006","unstructured":"Acampa M, Guideri F (2006) Cardiac disease and Rett syndrome. Arch Dis Child 91:440\u2013443","journal-title":"Arch Dis Child"},{"key":"10802_CR108","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1159\/000491610","volume":"47","author":"C Wang","year":"2018","unstructured":"Wang C, Wang F, Cao Q, Li Z, Huang L, Chen S (2018) The effect of Mecp2 on heart failure. Cell Physiol Biochem 47:2380\u20132387","journal-title":"Cell Physiol Biochem"},{"key":"10802_CR109","first-page":"3029","volume":"25","author":"SM Kyle","year":"2016","unstructured":"Kyle SM, Saha PK, Brown HM, Chan LC, Justice MJ (2016) MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex. Hum Mol Genet 25:3029\u20133041","journal-title":"Hum Mol Genet"},{"key":"10802_CR110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2018.10.002","volume":"92","author":"SA Rose","year":"2019","unstructured":"Rose SA, Wass S, Jankowski JJ, Feldman JF, Djukic A (2019) Impaired visual search in children with Rett syndrome. Pediatr Neurol 92:26\u201331","journal-title":"Pediatr Neurol"},{"key":"10802_CR111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0387-7604(12)80183-5","volume":"12","author":"SS Budden","year":"1990","unstructured":"Budden SS, Myer EC, Butler IJ (1990) Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and \u03b2-endorphins. Brain Dev 12:81\u201384","journal-title":"Brain Dev"},{"key":"10802_CR112","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/09638280412331280280","volume":"26","author":"D Ryan","year":"2004","unstructured":"Ryan D, McGregor F, Akermanis M, Southwell K, Ramke M, Woodyatt G (2004) Facilitating communication in children with multiple disabilities: three case studies of girls with Rett syndrome. Disabil Rehabil 26:1268\u20131277","journal-title":"Disabil Rehabil"},{"key":"10802_CR113","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hipo.23455","volume":"32","author":"PM Horvath","year":"2022","unstructured":"Horvath PM, Piazza MK, Kavalali ET, Monteggia LM (2022) MeCP2 loss-of\u2010function dysregulates MicroRNAs regionally and disrupts excitatory\/inhibitory synaptic transmission balance. Hippocampus 32:610\u2013623","journal-title":"Hippocampus"},{"key":"10802_CR114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","volume":"5","author":"KKE Gadalla","year":"2017","unstructured":"Gadalla KKE, Vudhironarit T, Hector RD, Sinnett S, Bahey NG, Bailey MES, Gray SJ, Cobb SR (2017) Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome. Mol Ther Methods Clin Dev 5:180\u2013190","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10802_CR115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","volume":"81","author":"LV Zingman","year":"2007","unstructured":"Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A (2007) Aminoglycoside-induced translational read\u2010through in disease: overcoming nonsense mutations by Pharmacogenetic therapy. Clin Pharmacol Ther 81:99\u2013103","journal-title":"Clin Pharmacol Ther"},{"key":"10802_CR116","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40259-016-0157-6","volume":"30","author":"K Nagel-Wolfrum","year":"2016","unstructured":"Nagel-Wolfrum K, M\u00f6ller F, Penner I, Baasov T, Wolfrum U (2016) Targeting nonsense mutations in diseases with translational read-through-inducing drugs (TRIDs). BioDrugs 30:49\u201374","journal-title":"BioDrugs"},{"key":"10802_CR117","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Clinical Evaluator Training Group; ACT DMD Study Group (2017) Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:1489\u20131498","journal-title":"Lancet"},{"key":"10802_CR118","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1042\/BST0380498","volume":"38","author":"S Cobb","year":"2010","unstructured":"Cobb S, Guy J, Bird A (2010) Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans 38:498\u2013506","journal-title":"Biochem Soc Trans"},{"key":"10802_CR119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","volume":"468","author":"H-T Chao","year":"2010","unstructured":"Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu H-C, Heintz N (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468:263\u2013269","journal-title":"Nature"},{"key":"10802_CR120","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","volume":"32","author":"M Kron","year":"2012","unstructured":"Kron M, Howell CJ, Adams IT, Ransbottom M, Christian D, Ogier M, Katz DM (2012) Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci 32:13860\u201313872","journal-title":"J Neurosci"},{"key":"10802_CR121","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-973476","volume":"30","author":"GL Wenk","year":"1999","unstructured":"Wenk GL, Hauss-Wegrzyniak B (1999) Altered cholinergic function in the basal forebrain of girls with Rett syndrome. Neuropediatrics 30:125\u2013129","journal-title":"Neuropediatrics"},{"key":"10802_CR122","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","volume":"447","author":"J-C Roux","year":"2008","unstructured":"Roux J-C, Dura E, Villard L (2008) Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse. Neurosci Lett 447:82\u201386","journal-title":"Neurosci Lett"},{"key":"10802_CR123","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","volume":"49","author":"Q Chang","year":"2006","unstructured":"Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49:341\u2013348","journal-title":"Neuron"},{"key":"10802_CR124","doi-asserted-by":"crossref","unstructured":"Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M (2009) Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences.;106:2029\u201334","DOI":"10.1073\/pnas.0812394106"},{"key":"10802_CR125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","volume":"110","author":"CR Roe","year":"2002","unstructured":"Roe CR, Sweetman L, Roe DS, David F, Brunengraber H (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110:259\u2013269","journal-title":"J Clin Invest"},{"key":"10802_CR126","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","volume":"45","author":"CM Buchovecky","year":"2013","unstructured":"Buchovecky CM, Turley SD, Brown HM, Kyle SM, McDonald JG, Liu B, Pieper AA, Huang W, Katz DM, Russell DW (2013) A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat Genet 45:1013\u20131020","journal-title":"Nat Genet"},{"key":"10802_CR127","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/adc.80.5.470","volume":"80","author":"CJ Ellaway","year":"1999","unstructured":"Ellaway CJ, Sholler G, Leonard H, Christodoulou J (1999) Prolonged QT interval in Rett syndrome. Arch Dis Child 80:470\u2013472","journal-title":"Arch Dis Child"},{"key":"10802_CR128","doi-asserted-by":"crossref","unstructured":"Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proceedings of the National Academy of Sciences.;101:6033\u20138","DOI":"10.1073\/pnas.0401626101"},{"key":"10802_CR129","first-page":"784","volume":"8","author":"D Del Gaudio","year":"2006","unstructured":"Del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M (2006) Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Sci 8:784\u2013792","journal-title":"Genet Sci"},{"key":"10802_CR130","unstructured":"Meglio M Promising phase 1\/2 data released on Rett syndrome gene therapy agent TSHA-102. Neurology Live 2023:NA-NA."},{"key":"10802_CR131","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41431-020-0624-x","volume":"28","author":"S Croci","year":"2020","unstructured":"Croci S, Carriero ML, Capitani K, Daga S, Donati F, Frullanti E, Lamacchia V, Tita R, Giliberti A, Valentino F (2020) High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot. Eur J Hum Genet 28:1231\u20131242","journal-title":"Eur J Hum Genet"},{"key":"10802_CR132","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"key":"10802_CR133","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","volume":"43","author":"NA Kootstra","year":"2003","unstructured":"Kootstra NA, Verma IM (2003) Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43:413\u2013439","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10802_CR134","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymgme.2007.11.008","volume":"93","author":"C McIntyre","year":"2008","unstructured":"McIntyre C, Roberts ALD, Ranieri E, Clements PR, Byers S, Anson DS (2008) Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA. Mol Genet Metab 93:411\u2013418","journal-title":"Mol Genet Metab"},{"key":"10802_CR135","doi-asserted-by":"crossref","first-page":"747726","DOI":"10.3389\/fnins.2021.747726","volume":"15","author":"JM Fischell","year":"2021","unstructured":"Fischell JM, Fishman PS (2021) A multifaceted approach to optimizing AAV delivery to the brain for the treatment of neurodegenerative diseases. Front Neurosci 15:747726","journal-title":"Front Neurosci"},{"key":"10802_CR136","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/dmcn.15383","volume":"65","author":"N Panayotis","year":"2023","unstructured":"Panayotis N, Ehinger Y, Felix MS, Roux J (2023) State-of\u2010the\u2010art therapies for Rett syndrome. Dev Med Child Neurol 65:162\u2013170","journal-title":"Dev Med Child Neurol"},{"key":"10802_CR137","doi-asserted-by":"crossref","first-page":"e6810","DOI":"10.1371\/journal.pone.0006810","volume":"4","author":"M Rastegar","year":"2009","unstructured":"Rastegar M, Hotta A, Pasceri P, Makarem M, Cheung AYL, Elliott S, Park KJ, Adachi M, Jones FS, Clarke ID (2009) MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS ONE 4:e6810","journal-title":"PLoS ONE"},{"key":"10802_CR138","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","volume":"1","author":"RJ Samulski","year":"2014","unstructured":"Samulski RJ, Muzyczka N (2014) AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 1:427\u2013451","journal-title":"Annu Rev Virol"},{"key":"10802_CR139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","volume":"21","author":"KKE Gadalla","year":"2013","unstructured":"Gadalla KKE, Bailey MES, Spike RC, Ross PD, Woodard KT, Kalburgi SN, Bachaboina L, Deng JV, West AE, Samulski RJ (2013) Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther 21:18\u201330","journal-title":"Mol Ther"},{"key":"10802_CR140","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","volume":"33","author":"SK Garg","year":"2013","unstructured":"Garg SK, Lioy DT, Cheval H, McGann JC, Bissonnette JM, Murtha MJ, Foust KD, Kaspar BK, Bird A, Mandel G (2013) Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci 33:13612\u201313620","journal-title":"J Neurosci"},{"key":"10802_CR141","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1523\/JNEUROSCI.6000-11.2012","volume":"32","author":"ES Na","year":"2012","unstructured":"Na ES, Nelson ED, Adachi M, Autry AE, Mahgoub MA, Kavalali ET, Monteggia LM (2012) A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J Neurosci 32:3109\u20133117","journal-title":"J Neurosci"},{"key":"10802_CR142","doi-asserted-by":"crossref","first-page":"e00391","DOI":"10.1016\/j.neurot.2024.e00391","volume":"21","author":"J Wang","year":"2024","unstructured":"Wang J, Gao G, Wang D (2024) Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders. Neurotherapeutics 21:e00391","journal-title":"Neurotherapeutics"},{"key":"10802_CR143","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/hmg\/ddl099","volume":"15","author":"J Liu","year":"2006","unstructured":"Liu J, Francke U (2006) Identification of cis-regulatory elements for MECP2 expression. Hum Mol Genet 15:1769\u20131782","journal-title":"Hum Mol Genet"},{"key":"10802_CR144","first-page":"GE01","volume":"9","author":"M Ramamoorth","year":"2015","unstructured":"Ramamoorth M, Narvekar A (2015) Non viral vectors in gene therapy-an overview. J Clin Diagn Res 9:GE01","journal-title":"J Clin Diagn Res"},{"key":"10802_CR145","doi-asserted-by":"crossref","first-page":"1901081","DOI":"10.1002\/adma.201901081","volume":"32","author":"HJ Vaughan","year":"2020","unstructured":"Vaughan HJ, Green JJ, Tzeng SY (2020) Cancer-targeting nanoparticles for combinatorial nucleic acid delivery. Adv Mater 32:1901081","journal-title":"Adv Mater"},{"key":"10802_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-252","volume":"9","author":"SM Dizaj","year":"2014","unstructured":"Dizaj SM, Jafari S, Khosroushahi AY (2014) A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett 9:1\u20139","journal-title":"Nanoscale Res Lett"},{"key":"10802_CR147","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cbic.202000364","volume":"22","author":"G Moku","year":"2021","unstructured":"Moku G, Vangala S, Gulla SK, Yakati V (2021) In vivo targeting of DNA vaccines to dendritic cells via the mannose receptor induces long-lasting immunity against melanoma. ChemBioChem 22:523\u2013531","journal-title":"ChemBioChem"},{"key":"10802_CR148","doi-asserted-by":"crossref","first-page":"601626","DOI":"10.3389\/fphar.2021.601626","volume":"12","author":"A Gagliardi","year":"2021","unstructured":"Gagliardi A, Giuliano E, Venkateswararao E, Fresta M, Bulotta S, Awasthi V, Cosco D (2021) Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol 12:601626","journal-title":"Front Pharmacol"},{"key":"10802_CR149","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W, Li W, Liu X, Peng H, Wang Q (2021) Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale 13:10748\u201310764","journal-title":"Nanoscale"},{"key":"10802_CR150","doi-asserted-by":"crossref","unstructured":"Guo Z, Zhang P, Chakraborty S, Chetwynd AJ, Abdolahpur Monikh F, Stark C, Ali-Boucetta H, Wilson S, Lynch I, Valsami-Jones E (2021) Biotransformation modulates the penetration of metallic nanomaterials across an artificial blood\u2013brain barrier model. Proceedings of the National Academy of Sciences.;118:e2105245118","DOI":"10.1073\/pnas.2105245118"},{"key":"10802_CR151","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","volume":"11","author":"JV Gregory","year":"2020","unstructured":"Gregory JV, Kadiyala P, Doherty R, Cadena M, Habeel S, Ruoslahti E, Lowenstein PR, Castro MG, Lahann J (2020) Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy. Nat Commun 11:5687","journal-title":"Nat Commun"},{"key":"10802_CR152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2020.02.006","volume":"165","author":"MJ Fowler","year":"2020","unstructured":"Fowler MJ, Cotter JD, Knight BE, Sevick-Muraca EM, Sandberg DI, Sirianni RW (2020) Intrathecal drug delivery in the era of nanomedicine. Adv Drug Deliv Rev 165:77\u201395","journal-title":"Adv Drug Deliv Rev"},{"key":"10802_CR153","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1007\/s11033-019-04983-5","volume":"46","author":"C Duma","year":"2019","unstructured":"Duma C, Kopyov O, Kopyov A, Berman M, Lander E, Elam M, Arata M, Weiland D, Cannell R, Caraway C (2019) Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol Biol Rep 46:5257\u20135272","journal-title":"Mol Biol Rep"},{"key":"10802_CR154","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbi.2020.06.032","volume":"89","author":"B Bryche","year":"2020","unstructured":"Bryche B, St Albin A, Murri S, Lac\u00f4te S, Pulido C, Gouilh MA, Lesellier S, Servat A, Wasniewski M, Picard-Meyer E (2020) Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun 89:579\u2013586","journal-title":"Brain Behav Immun"},{"key":"10802_CR155","doi-asserted-by":"crossref","first-page":"100045","DOI":"10.1016\/j.rare.2024.100045","volume":"2","author":"K Ramsey","year":"2024","unstructured":"Ramsey K, LaFleur M, Robinson K, Borgstrom M, Ryan A, Narayanan V, Schaibley V (2024) Family and caregiver perspectives on gene therapy for Rett syndrome. Rare 2:100045","journal-title":"Rare"},{"key":"10802_CR156","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13023-022-02576-3","volume":"18","author":"T Collin-Histed","year":"2023","unstructured":"Collin-Histed T, Rosenberg A, Hopman N, Pacey J (2023) Understanding patient and parent\/caregiver perceptions on gene therapy in gaucher disease: an international survey. Orphanet J Rare Dis 18:5","journal-title":"Orphanet J Rare Dis"},{"key":"10802_CR157","unstructured":"Marisa Wexler FDA moves to support TSHA-102, potential Rett gene therapy 2024"},{"key":"10802_CR158","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.3390\/ijms20205098","volume":"20","author":"SD Kadam","year":"2019","unstructured":"Kadam SD, Sullivan BJ, Goyal A, Blue ME, Smith-Hicks C (2019) Rett syndrome and CDKL5 deficiency disorder: from bench to clinic. Int J Mol Sci 20:5098","journal-title":"Int J Mol Sci"},{"key":"10802_CR159","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1017\/S0266462324000333","volume":"40","author":"A Supian","year":"2024","unstructured":"Supian A, Shafie AA, Ngu L-H, Ayob H, Chaiyakunapruk N (2024) Perceptions of patients and caregivers toward the management of rare disease in malaysia: a qualitative research study. Int J Technol Assess Health Care 40:e34","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10802-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10802-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:25:59Z","timestamp":1766895959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10802-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10802"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10802-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliation details for the author \u2018Adil Abalkhail\u2019 have been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors approved the final version of the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"687"}}